Home › Free Stock Grades › CRL
Charles River Laboratories International, Inc. (CRL) Stock Grade
CRL · Healthcare
D+
Market Cap
$14.2B
P/E Ratio
—
Revenue Growth (YoY)
-0.9%
Net Margin
-3.6%
Return on Equity
—
Dividend Yield
None
About Charles River Laboratories International, Inc.'s fundamentals
Charles River Laboratories is a $14.2 billion healthcare company that experienced a slight revenue contraction of 0.9% year-over-year and reported a net loss with a negative margin of -3.6% in its latest annual period. Despite the accounting losses, the company maintained positive free cash flow, indicating that operational cash generation remains intact. The company does not currently pay a dividend to shareholders.